Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP691860.RAFEN-jA5DAHoAKB-Wv28HlWIjZ9iw_QxAPZnVZsRMLH0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP691860.RAFEN-jA5DAHoAKB-Wv28HlWIjZ9iw_QxAPZnVZsRMLH0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP691860.RAFEN-jA5DAHoAKB-Wv28HlWIjZ9iw_QxAPZnVZsRMLH0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP691860.RAFEN-jA5DAHoAKB-Wv28HlWIjZ9iw_QxAPZnVZsRMLH0130_provenance.
- NP691860.RAFEN-jA5DAHoAKB-Wv28HlWIjZ9iw_QxAPZnVZsRMLH0130_assertion wasGeneratedBy ECO_0000203 NP691860.RAFEN-jA5DAHoAKB-Wv28HlWIjZ9iw_QxAPZnVZsRMLH0130_provenance.
- NP691860.RAFEN-jA5DAHoAKB-Wv28HlWIjZ9iw_QxAPZnVZsRMLH0130_assertion wasDerivedFrom befree-20140225 NP691860.RAFEN-jA5DAHoAKB-Wv28HlWIjZ9iw_QxAPZnVZsRMLH0130_provenance.
- NP691860.RAFEN-jA5DAHoAKB-Wv28HlWIjZ9iw_QxAPZnVZsRMLH0130_assertion SIO_000772 23658459 NP691860.RAFEN-jA5DAHoAKB-Wv28HlWIjZ9iw_QxAPZnVZsRMLH0130_provenance.
- NP691860.RAFEN-jA5DAHoAKB-Wv28HlWIjZ9iw_QxAPZnVZsRMLH0130_assertion evidence source_evidence_literature NP691860.RAFEN-jA5DAHoAKB-Wv28HlWIjZ9iw_QxAPZnVZsRMLH0130_provenance.
- NP691860.RAFEN-jA5DAHoAKB-Wv28HlWIjZ9iw_QxAPZnVZsRMLH0130_assertion description "[Dovitinib was then evaluated in a phase II trial that included 4 groups of patients with human EGF receptor 2-negative metastatic breast cancer on the basis of FGFR1 amplification and hormone receptor (HR) status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691860.RAFEN-jA5DAHoAKB-Wv28HlWIjZ9iw_QxAPZnVZsRMLH0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP691860.RAFEN-jA5DAHoAKB-Wv28HlWIjZ9iw_QxAPZnVZsRMLH0130_provenance.